| scholarly article | Q13442814 |
| P50 | author | Daniel A. Portnoy | Q26737169 |
| Erik S Van Dis | Q61124739 | ||
| P2093 | author name string | Chris S Rae | |
| Tom Evans | |||
| Nathalie Cadieux | |||
| Sarah A Stanley | |||
| Thomas W Dubensky | |||
| Sarah M McWhirter | |||
| Kartoosh Heydari | |||
| David B Kanne | |||
| Jacob R Bruml | |||
| Justin J Leong | |||
| Kelsey E Sivick | |||
| Ken Metchette | |||
| Kimberly M Sogi | |||
| Meredith L Leong | |||
| Natalie H Surh | |||
| Vivian Chen | |||
| P2860 | cites work | Roles of cyclic diguanylate in the regulation of bacterial pathogenesis | Q24656979 |
| Rationale, progress and development of vaccines utilizing STING-activating cyclic dinucleotide adjuvants | Q27025822 | ||
| A gamma interferon independent mechanism of CD4 T cell mediated control of M. tuberculosis infection in vivo | Q27349862 | ||
| The HyVac4 subunit vaccine efficiently boosts BCG-primed anti-mycobacterial protective immunity | Q28727776 | ||
| An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection | Q29616521 | ||
| Single nucleotide polymorphisms of human STING can affect innate immune response to cyclic dinucleotides | Q21132463 | ||
| Activation of STAT6 by STING is critical for antiviral innate immunity | Q24293312 | ||
| STING is an endoplasmic reticulum adaptor that facilitates innate immune signalling | Q24336398 | ||
| STING is a direct innate immune sensor of cyclic di-GMP | Q24633648 | ||
| A host type I interferon response is induced by cytosolic sensing of the bacterial second messenger cyclic-di-GMP | Q24642631 | ||
| MF59. Design and evaluation of a safe and potent adjuvant for human vaccines | Q40408021 | ||
| Mycobacterium tuberculosis Differentially Activates cGAS- and Inflammasome-Dependent Intracellular Immune Responses through ESX-1. | Q41181573 | ||
| IFN-γ from CD4 T cells is essential for host survival and enhances CD8 T cell function during Mycobacterium tuberculosis infection. | Q41764389 | ||
| Specific T cell frequency and cytokine expression profile do not correlate with protection against tuberculosis after bacillus Calmette-Guérin vaccination of newborns | Q41775340 | ||
| One-flask syntheses of c-di-GMP and the [Rp,Rp] and [Rp,Sp] thiophosphate analogues | Q42732138 | ||
| The member of the cyclic di-nucleotide family bis-(3', 5')-cyclic dimeric inosine monophosphate exerts potent activity as mucosal adjuvant | Q43198955 | ||
| Bis-(3',5')-cyclic dimeric adenosine monophosphate: strong Th1/Th2/Th17 promoting mucosal adjuvant | Q44205583 | ||
| Bacterial c-di-GMP is an immunostimulatory molecule | Q44754791 | ||
| c-di-GMP as a vaccine adjuvant enhances protection against systemic methicillin-resistant Staphylococcus aureus (MRSA) infection. | Q46030297 | ||
| Interrupted BCG vaccination is a major threat to global child health | Q46650004 | ||
| Vaccine-elicited memory CD4+ T cell expansion is impaired in the lungs during tuberculosis | Q47141135 | ||
| Differential immune responses and protective efficacy induced by components of a tuberculosis polyprotein vaccine, Mtb72F, delivered as naked DNA or recombinant protein | Q47371281 | ||
| Vaccines for the twenty-first century society. | Q51664205 | ||
| A multistage tuberculosis vaccine that confers efficient protection before and after exposure. | Q54391413 | ||
| MPYS/STING-mediated TNF-α, not type I IFN, is essential for the mucosal adjuvant activity of (3'-5')-cyclic-di-guanosine-monophosphate in vivo. | Q54487555 | ||
| The Development and Impact of Tuberculosis Vaccines | Q56766328 | ||
| IL-23 and IL-17 in the establishment of protective pulmonary CD4+ T cell responses after vaccination and during Mycobacterium tuberculosis challenge | Q58518610 | ||
| Protection of macaques against Mycobacterium tuberculosis infection by a subunit vaccine based on a fusion protein of antigen 85B and ESAT-6 | Q58827826 | ||
| The bacterial second messenger cyclic diGMP exhibits potent adjuvant properties | Q79450264 | ||
| 3',5'-Cyclic diguanylic acid elicits mucosal immunity against bacterial infection | Q84250609 | ||
| Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial | Q29620144 | ||
| Intranasal c-di-GMP-adjuvanted plant-derived H5 influenza vaccine induces multifunctional Th1 CD4+ cells and strong mucosal and systemic antibody responses in mice | Q30402980 | ||
| Whole genome identification of Mycobacterium tuberculosis vaccine candidates by comprehensive data mining and bioinformatic analyses | Q31156691 | ||
| Cationic liposomes formulated with synthetic mycobacterial cordfactor (CAF01): a versatile adjuvant for vaccines with different immunological requirements | Q33367582 | ||
| Cutting edge: control of Mycobacterium tuberculosis infection by a subset of lung parenchyma-homing CD4 T cells | Q33566339 | ||
| Unexpected role for IL-17 in protective immunity against hypervirulent Mycobacterium tuberculosis HN878 infection. | Q33619034 | ||
| Evaluation of new vaccines in the mouse and guinea pig model of tuberculosis | Q33755534 | ||
| Comparative evaluation of low-molecular-mass proteins from Mycobacterium tuberculosis identifies members of the ESAT-6 family as immunodominant T-cell antigens | Q34003037 | ||
| ESAT-6 subunit vaccination against Mycobacterium tuberculosis | Q34003301 | ||
| Protection of mice with a tuberculosis subunit vaccine based on a fusion protein of antigen 85b and esat-6. | Q34007101 | ||
| The N-ethyl-N-nitrosourea-induced Goldenticket mouse mutant reveals an essential function of Sting in the in vivo interferon response to Listeria monocytogenes and cyclic dinucleotides | Q34151349 | ||
| STING and the innate immune response to nucleic acids in the cytosol | Q34317532 | ||
| IL-23 compensates for the absence of IL-12p70 and is essential for the IL-17 response during tuberculosis but is dispensable for protection and antigen-specific IFN-gamma responses if IL-12p70 is available | Q34432140 | ||
| Protective immunity against tuberculosis induced by vaccination with major extracellular proteins of Mycobacterium tuberculosis | Q34629227 | ||
| Regulation of adaptive immunity by the innate immune system | Q34659642 | ||
| STING ligand c-di-GMP improves cancer vaccination against metastatic breast cancer | Q34687752 | ||
| A defined tuberculosis vaccine candidate boosts BCG and protects against multidrug-resistant Mycobacterium tuberculosis | Q35033838 | ||
| STING-dependent cytosolic DNA sensing mediates innate immune recognition of immunogenic tumors. | Q35263440 | ||
| A bacterial cyclic dinucleotide activates the cytosolic surveillance pathway and mediates innate resistance to tuberculosis. | Q35328612 | ||
| Direct Activation of STING in the Tumor Microenvironment Leads to Potent and Systemic Tumor Regression and Immunity | Q35634752 | ||
| The Cytosolic Sensor cGAS Detects Mycobacterium tuberculosis DNA to Induce Type I Interferons and Activate Autophagy | Q35738682 | ||
| The importance of adjuvant formulation in the development of a tuberculosis vaccine | Q35783475 | ||
| Nanoparticulate STING agonists are potent lymph node-targeted vaccine adjuvants. | Q35836140 | ||
| The bacterial second messenger cdiGMP exhibits promising activity as a mucosal adjuvant | Q36097099 | ||
| Cyclic di-GMP stimulates protective innate immunity in bacterial pneumonia | Q36097274 | ||
| The success and failure of BCG - implications for a novel tuberculosis vaccine | Q36191944 | ||
| T-cell activation is an immune correlate of risk in BCG vaccinated infants | Q36799172 | ||
| Novel adjuvant formulations for delivery of anti-tuberculosis vaccine candidates | Q36909492 | ||
| The host STING pathway at the interface of cancer and immunity | Q37042237 | ||
| c-di-GMP is an effective immunomodulator and vaccine adjuvant against pneumococcal infection. | Q37109444 | ||
| Subunit vaccine H56/CAF01 induces a population of circulating CD4 T cells that traffic into the Mycobacterium tuberculosis-infected lung | Q37666257 | ||
| Tuberculosis vaccine development at a divide | Q38195728 | ||
| Protective effect of a tuberculosis subunit vaccine based on a fusion of antigen 85B and ESAT-6 in the aerosol guinea pig model | Q38449050 | ||
| Novel approaches to tuberculosis vaccine development | Q38999845 | ||
| A Multistage Subunit Vaccine Effectively Protects Mice Against Primary Progressive Tuberculosis, Latency and Reactivation | Q40133620 | ||
| P433 | issue | 5 | |
| P921 | main subject | Mycobacterium tuberculosis | Q130971 |
| P304 | page(s) | 1435-1447 | |
| P577 | publication date | 2018-05-01 | |
| P1433 | published in | Cell Reports | Q5058165 |
| P1476 | title | STING-Activating Adjuvants Elicit a Th17 Immune Response and Protect against Mycobacterium tuberculosis Infection. | |
| P478 | volume | 23 |
| Q92227095 | A SNP upstream of the cyclic GMP-AMP synthase (cGAS) gene protects from relapse and extra-pulmonary TB and relates to BCG vaccination status in an Indian cohort |
| Q92597111 | Adjuvant Strategies for More Effective Tuberculosis Vaccine Immunity |
| Q64256617 | Cell Differentiation Degree as a Factor Determining the Role for Different T-Helper Populations in Tuberculosis Protection |
| Q93168696 | Comparison of adjuvants to optimize influenza neutralizing antibody responses |
| Q92267263 | DNA sensing by the cGAS-STING pathway in health and disease |
| Q93013037 | Diminished stimulator of interferon genes production with cigarette smoke-exposure contributes to weakened anti-adenovirus vectors response and destruction of lung in chronic obstructive pulmonary disease model |
| Q62736465 | Mucosal boosting of H56:CAF01 immunization promotes lung-localized T cells and an accelerated pulmonary response to Mycobacterium tuberculosis infection without enhancing vaccine protection |
| Q100305090 | Programming Multifaceted Pulmonary T Cell Immunity by Combination Adjuvants |
| Q94921871 | Research Advances in How the cGAS-STING Pathway Controls the Cellular Inflammatory Response |
| Q91890877 | STING signaling and host defense against microbial infection |
| Q90147842 | Selection of adjuvants for vaccines targeting specific pathogens |
Search more.